Department of Quality & Safety, NYC Health + Hospitals, New York, NY; Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, NY.
Department of Anesthesia, Icahn School of Medicine, New York, NY.
Am J Infect Control. 2023 Jul;51(7):786-791. doi: 10.1016/j.ajic.2022.11.003. Epub 2022 Nov 10.
Clostridioides difficile (C. difficile) is a hospital-acquired infection. Overtesting for C. difficile leads to false positive results due to a high rate of asymptomatic colonization, resulting in unnecessary and harmful treatment for patients.
This was a quality improvement initiative to decrease the rate of inappropriate C. difficile testing across 11 hospitals in an urban, safety-net setting. Three best practice advisories were created, alerting providers of recent laxative administration within 48 hours, a recent positive test within 14 days, and a recent negative test within 7 days. The outcome measures were the number of C. difficile tests per 1,000 patient days, as well as the rate of hospital onset C. difficile infection was compared pre- and post-intervention. The process measures included the rate of removal of the C. difficile test from the best practice advisory, as well as the subsequent 24-hour re-order rate.
The number of C. difficile tests decreased by 27.3% from 1.1 per 1,000 patient days preintervention (May 25, 2020-May 24, 2021) to 0.8 per 1,000 patient days postintervention, (May 25, 2021-March 25, 2022), P < .001. When stratified by hospital, changes in testing ranged from an increase of 12.5% to a decrease of 60%. Analysis among provider type showed higher behavior change among attendings than compared to trainees or advanced practice providers. There was a 12.1%, nonsignificant decrease in C. difficile rates from preintervention, 0.33 per 1,000 patient days compared to postintervention, 0.29 per 1,000 patient days, P=.32.
Using only an electronic health record intervention, we successfully decreased C. difficile orders after 72 hours of admission in a large, safety-net system. Variation existed among hospitals and by provider type.
艰难梭菌(C. difficile)是一种医院获得性感染。过度检测艰难梭菌会导致假阳性结果,因为无症状定植率很高,从而对患者进行不必要和有害的治疗。
这是一项质量改进计划,旨在减少在城市安全网环境中的 11 家医院中不适当的艰难梭菌检测率。制定了三项最佳实践建议,提醒医生注意在 48 小时内最近使用过泻药、在 14 天内最近有阳性检测结果以及在 7 天内最近有阴性检测结果。主要结果是每 1000 个患者天的艰难梭菌检测数量,以及干预前后医院获得性艰难梭菌感染的发生率。过程测量包括从最佳实践建议中删除艰难梭菌检测的比例,以及随后 24 小时的重新订购率。
从干预前的每 1000 个患者天 1.1 次(2020 年 5 月 25 日至 2021 年 5 月 24 日)减少到干预后的每 1000 个患者天 0.8 次(2021 年 5 月 25 日至 2022 年 3 月 25 日),P<.001。按医院分层,检测的变化范围从增加 12.5%到减少 60%。对医生类型的分析显示,主治医生的行为改变率高于住院医师或高级执业医师。干预前艰难梭菌的发生率为 0.33/1000 患者天,与干预后相比略有下降,为 0.29/1000 患者天,P=.32。
仅使用电子健康记录干预措施,我们就在一个大型安全网系统中成功地减少了入院后 72 小时内的艰难梭菌订单。各医院之间和医生类型之间存在差异。